YK-11 is considered a combination between a SARM due to its high selectivity in activating androgen receptors and a steroid due to its chemical structure.
How it works
Its special characteristic is that it very effectively inhibits myostatin, by drastically inducing the release of follistatin, acting better than exogenous follistatin .
*Side effects
Its side effects are very similar to the rest of the SARMs:
️Worsening of the lipid profile. ️Hepatic stress. ️Hormonal axis suppression.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.